How Amgen & HealthVerity found treatment gaps in high-risk diabetes care
Amgen’s new retrospective study, VESALIUS-REAL, examines how lipid-lowering therapy (LLT) is being...
The Marketplace model is winning: key insights from our webinar
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not just a trend. It is reshaping how life sciences organizations access, manage, and activate real-world data to support everything from R&D to...
Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
What is PPRL? A smarter way to link data securely and accurately
In this edition of our Ask an Expert series, we turn to Emery Niemiec, Principal of Government...
Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
How government agencies use HealthVerity for public health and AI-powered research
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity Notes: The hidden goldmine in healthcare data
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
Building better AI mortality models with Verified data
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
HealthVerity real-world data supports CDC study on HIV PrEP surveillance
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
The Marketplace model is winning: key insights from our webinar
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...